Provided by Tiger Trade Technology Pte. Ltd.

West Pharmaceutical

341.11
+3.641.08%
Post-market: 341.110.00000.00%19:32 EDT
Volume:615.60K
Turnover:209.83M
Market Cap:24.10B
PE:43.68
High:342.59
Open:336.25
Low:335.51
Close:337.47
52wk High:386.00
52wk Low:223.83
Shares:70.65M
Float Shares:69.93M
Volume Ratio:1.43
T/O Rate:0.88%
Dividend:0.87
Dividend Rate:0.26%
EPS(TTM):7.81
EPS(LYR):6.79
ROE:19.09%
ROA:11.38%
PB:8.06
PE(LYR):50.24

Loading ...

S&P 500 Futures Drop In Premarket Trading; Houlihan Lokey, Medpace Holdings Lag

Dow Jones
·
Apr 23

Stock Track | West Pharmaceutical Soars 9.33% in Pre-Market on Strong Q1 Results and Raised Guidance

Stock Track
·
Apr 23

West Pharma lifts 2026 profit forecast on strong demand for medical equipment

Reuters
·
Apr 23

West Pharmaceutical sees Q2 adjusted EPS $2.05-$2.12, consensus $2.00

TIPRANKS
·
Apr 23

West Pharmaceutical ups FY26 adjusted EPS view to $8.40-$8.75 from $7.85-$8.20

TIPRANKS
·
Apr 23

West Pharmaceutical reports Q1 adjusted EPS $2.13, consensus $1.68

TIPRANKS
·
Apr 23

GUIDANCE: (WST) West Pharmaceutical Expects 2026 Revenue Range $3.3B - $3.35B, vs. FactSet Est of $3.25B

MT Newswires Live
·
Apr 23

West Pharmaceutical Servs Q1 Adj. EPS $2.13 Beats $1.68 Estimate, Sales $844.900M Beat $779.974M Estimate

Benzinga Earnings
·
Apr 23

West Pharmaceutical Services Inc - Q2 Net Sales Guidance $830-$850 Mln, up 8.3%-10.9% Reported

THOMSON REUTERS
·
Apr 23

West Reports First-Quarter 2026 Results

THOMSON REUTERS
·
Apr 23

West Pharmaceutical Q1 EPS USD 1.92

THOMSON REUTERS
·
Apr 23

West Pharmaceutical Services Inc - Effective in Q1 2026, Co Renamed "Contract-Manufactured Products" Reportable Segment to "West Vantage"

THOMSON REUTERS
·
Apr 23

What to Watch in the Day Ahead - Thursday, April 23

Reuters
·
Apr 23

West Pharmaceutical Services Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Apr 21

West Pharmaceutical Services Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Apr 17

Earning Preview: West Pharmaceutical this quarter’s revenue is expected to increase by 13.73%, and institutional views are bullish

Earnings Agent
·
Apr 16

West Pharma Is Maintained at Equal-Weight by Barclays

Dow Jones
·
Apr 15

Barclays Adjusts Price Target on West Pharmaceutical Services to $275 From $265, Maintains Equalweight Rating

MT Newswires Live
·
Apr 14

West Pharmaceutical Services Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Apr 14

West Pharmaceutical Services Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Apr 10